SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-162369
Filing Date
2015-04-30
Accepted
2015-04-30 16:51:43
Documents
5
Period of Report
2015-06-26
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d916483ddef14a.htm DEF 14A 273692
2 GRAPHIC g916483g25m22.jpg GRAPHIC 28515
3 GRAPHIC g916483g36o41.jpg GRAPHIC 50943
4 GRAPHIC g916483ima001.jpg GRAPHIC 122757
5 GRAPHIC g916483ima002.jpg GRAPHIC 112314
  Complete submission text file 0001193125-15-162369.txt   708689
Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36579 | Film No.: 15819673
SIC: 2836 Biological Products, (No Diagnostic Substances)